期刊文献+

精神分裂症住院患者合并躯体疾病的相关因素分析 被引量:5

Schizophrenic Patients with Somatic Diseases Investigation and Analysis
原文传递
导出
摘要 目的:对精神分裂症住院患者合并躯体疾病的发生率及相关因素进行调查分析。方法:选择在我院住院治疗的精神分裂症患者682例,采用自制调查表进行统计分析,调查项目包括性别、年龄、总病程、躯体疾病诊断及精神科用药情况。结果:862例患者合并躯体疾病的发生率为60.9%,躯体疾病发生率随年龄增长及病程延长而增加,联合用药及使用非典型抗精神病药治疗精神分裂症比单一使用典型抗精神病药更易合并躯体疾病(P<0.01)。结论:精神分裂症住院患者合并躯体疾病的比例较高,对躯体疾病要及时治疗,减少患者疾病负担。 Objective:To investigate the prevalence rate of physical disease and risk factors among schizophrenicinpatients. Methods:self-made questionnaire was used in 862 patients in our hospital hospitalization in order to statistical analysis, the survey included gender, age, total duration of disease, the diagnosis of somatic physical disease and psychiatric medications.Results: 862 cases of patients with physical illness incidence rate of 60.9%, physical disease incidence increased with age and the extension of the course, combination therapy and the use of atypical antipsychotic treatment of schizophrenia than the single use of typical antipsychotics more likely to merge physical disease (P 0.01). Conclusions:The high proportion of schizophrenic patients with physical disease, timely treatment to reduce the burden of disease in patients with physical disease.
作者 杨雪 王朔
出处 《中国伤残医学》 2013年第3期30-31,共2页 Chinese Journal of Trauma and Disability Medicine
关键词 精神分裂症 住院患者 躯体疾病 Schizophrenia Hospitalized patients Physical disease
  • 相关文献

参考文献8

  • 1Lahti M, Tiihonen J, Wildgust H, et al. Cardiovascular morbidity, mortality and pharmacotherapy in patients with?schizophrenia[J] Psychol Med. 2012 Mar 12:1-1 1.
  • 2李春阳.精神分裂症住院患者合并躯体疾病临床分析[J].临床精神医学杂志,2006,16(2):100-101. 被引量:37
  • 3Nyboe L, Videbech P. Metabolic syndrome in schizophrenia[J] Ugeskr Laeger. 2010 Dec 6;172(49):3399-404.
  • 4吉中孚.第二代抗精神病药安全性评价[J].中国医院用药评价与分析,2008,8(4):257-260. 被引量:28
  • 5司天梅,刘艳.精神分裂症患者的代谢综合征风险[J].精神医学杂志,2009,22(1):66-69. 被引量:27
  • 6Laursen TM,Munk-Olsen T,Gasse C.Chronic somatic comorbidity and excess mortality due to natural causes in persons withschizophrenia or bipolar affective disorder[J] PLoS One. 2011; 6(9):e24597.
  • 7R 6 thelyi J, Sawalhe AD. Comorbidity of metabolic syndrome, diabetes and schizophrenia: theoretical and practical considerations [J] 0rv Hetil. 2011 Mar 27;152(13):505N1 I.
  • 8JukiV,Petrovi Z,Breci P, et al.Psychofannacology in the prevention of somatic comorbid diseases in mentally ill patients[J] Psychiatr Danub. 2009 Sep;21(3):350-5.

二级参考文献32

  • 1张玉梅,张晓斌,黄啸.长期住院精神分裂症患者伴发糖尿病与迟发性运动障碍的研究[J].四川精神卫生,2005,18(1):5-7. 被引量:6
  • 2冯少慧,曾林,刘修军.238例共患躯体疾病老年精神障碍临床分析[J].临床精神医学杂志,2005,15(2):82-83. 被引量:18
  • 3沈渔村.精神病学(第3版)[M].北京:人民卫生出版社,1999.805-828.
  • 4福井秀明 李雪荣 译.抗精神病药物所致的周期性麻痹[J].国外医学:精神病学分册,1990,17:93-93.
  • 5Kinon B J, Basson BR, Gilmore JA, et al. Long - term olanzapine treatment: weight change and weight - related heahh factors in schizophrenia [J]. J Clin Psychiatry,2001, 62(2) :92.
  • 6Allison DB, Mentore JL, Heo M, et al. Antipsychotic- induce weight gain: comprehensive research synthesis [J].Am J Psychiatry, 1999, 156( 11 ) : 1 681.
  • 7Allison DB, Casey DE. Antipsychotic- induced weight gain: a review of the literature [J]. J Clin Psychiatry, 2001,62 (suppl 7) :22.
  • 8Taylor D, Paton C, Kerwin R. The maudsleyprescribing guidelines [ M ]. 7th edition. London : Martin Dunitz, 2003.
  • 9Herrmann N and Lanctot K. Atypical antipsychotics for neuropsychiatric symptoms of dementia [J]. Drug safety, 2006,29(10) :833.
  • 10Aronn LJ. Epidemiology morbidity, and treatment of overweight and obesity [ J ] . J Clin Psychiatry, 2001,62 ( suppl 23) : 13.

共引文献86

同被引文献33

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部